|
|
||||||||
Regular Article |
Received March 9, 2001; revised May 20, June 12, 2001; accepted June 14, 2001. From the Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania. Address correspondence to Dr. Katz, University of Pennsylvania School of Medicine, Department of Psychiatry, 3600 Market St., Philadelphia, PA 19104. e-mail: katzi{at}mail.med.upenn.edu
The authors evaluated the cognitive and psychomotor effects of serotonin reuptake inhibitors in healthy elderly volunteers. Paroxetine, sertraline, and placebo were compared for 3 weeks of testing in a double-blind study with behavioral testing at baseline and at the end of each week. MANOVA models demonstrated no between-group differences; however, mixed-model random regression analyses revealed that Day 14 plasma paroxetine levels correlated negatively with delayed verbal recall and paired-associate learning scores. In contrast, plasma sertraline levels correlated positively with Day 7 immediate verbal recall, Day 14 tapping, and Day 21 delayed verbal recall scores, and negatively with divided-attention task scores on Day 21. Plasma paroxetine levels were associated with mild behavioral impairment at Day 14, with no other significant adverse effects. Plasma sertraline levels were associated with mild and transient behavioral changes, as well as early termination in several subjects.
Key Words: Selective Serotonin Reuptake Inhibitors (SSRIs) Side Effects Sertraline Paroxetine
This article has been cited by other articles:
![]() |
L. G. Chepenik, T. T. Have, D. Oslin, C. Datto, C. Zubritsky, and I. R. Katz A Daily Diary Study of Late-Life Depression Am J Geriatr Psychiatry, March 1, 2006; 14(3): 270 - 279. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. E. Lotrich and B. G. Pollock Aging and Clinical Pharmacology: Implications for Antidepressants J. Clin. Pharmacol., October 1, 2005; 45(10): 1106 - 1122. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Munro, J. Brandt, J.-M. E. Sheppard, C. D. Steele, Q. M. Samus, M. Steinberg, P. V. Rabins, and C. G. Lyketsos Cognitive Response to Pharmacological Treatment for Depression in Alzheimer Disease: Secondary Outcomes From the Depression in Alzheimer's Disease Study (DIADS) Am J Geriatr Psychiatry, October 1, 2004; 12(5): 491 - 498. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Furlan, M. J. Kallan, T. T. Have, I. Lucki, and I. Katz SSRIs Do Not Cause Affective Blunting in Healthy Elderly Volunteers Am J Geriatr Psychiatry, June 1, 2004; 12(3): 323 - 330. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Doraiswamy, K. R. R. Krishnan, T. Oxman, L. R. Jenkyn, D. J. Coffey, T. Burt, and C. M. Clary Does Antidepressant Therapy Improve Cognition in Elderly Depressed Patients? J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2003; 58(12): M1137 - 1144. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D Joss, R. M Burton, and C. A Keller Memory Loss in a Patient Treated with Fluoxetine Ann. Pharmacother., December 1, 2003; 37(12): 1800 - 1803. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. G. Pollock Biomarkers: From Bedside to Bench and Back Again Am J Geriatr Psychiatry, December 1, 2002; 10(6): 644 - 645. [Full Text] [PDF] |
||||
![]() |
R. R. Bies, M. R. Gastonguay, K. C. Coley, P. D. Kroboth, and B. G. Pollock Evaluating the Consistency of Pharmacotherapy Exposure by Use of State-of-the-Art Techniques Am J Geriatr Psychiatry, December 1, 2002; 10(6): 696 - 705. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ALL ISSUES | SEARCH | TABLE OF CONTENTS |